Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia

Schizophrenia Research

Volumn 147, Issue 1, 2013, Pages 203-204

  Kerr, Daniel Shikanai ^a   Talib, Leda Leme ^a   Yamamoto, Victor Junji ^a   Ferreira, Aline S ^a   Zanetti, Marcus V ^a   Serpa, Mauricio H ^a   Busatto, Geraldo F ^a   Van de Bilt, Martinus Theodorus ^a   Gattaz, Wagner Farid ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CLOZAPINE; CYTOSOLIC PHOSPHOLIPASE A2; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; OLANZAPINE; SECRETORY PHOSPHOLIPASE A2;

ADULT; B2M GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GSTP1 GENE; HUMAN; IPLA2 GENE; LETTER; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; FEMALE; GENE EXPRESSION REGULATION; GROUP VI PHOSPHOLIPASES A2; HUMANS; MALE; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 84877108068     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.026     Document Type: Letter

References (8)

1. Dennis E.A., Cao J., Hsu Y.H., Magrioti V., Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 2011, 12;111(10):6130-6185.
2. Gattaz W.F., Köllisch M., Thuren T., Virtanen J.A., Kinnunen P.K. Increased plasma phospholipase-a2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol. Psychiatry 1987, 22:421-426.
3. Gattaz W.F., Valente K.D., Raposo N.R.B., Vincentiis S., Talib L.L. Increased pla2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis. J. Psychiatr. Res. 2011, 45:1617-1620.
4. Green J.T., Orr S.K., Bazinet R.P. The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexanoic acid from brain phospholipids. J. Lipid Res. 2008, 49:939-944.
5. Kudo I., Murakami M. Phospholipase a2 enzymes. Prostaglandins Other Lipid Mediat. 2002, 68-69:3-58.
6. Pfaffl M.W. A new mathematical model for relative quantification in real-time rt-pcr. Nucleic Acids Res. 2001, 29:e45.
7. Ross B.M., Hughes B., Kish S.J., Warsh J.J. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disord. 2006, 8(3):265-270.
8. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative rt-pcr data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (p. RESEARCH0034).